Zhou et al. combined morphine with ketamine in the treatments of refractory cancer pain and found that drug combinations effectively decrease the levels of IL-2 and IFN-γ in T cell isolated from patients with cancer pain [19]. This evidence concerns the gene IL2 and cancer.